Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions - Summary of Asset Acquisition (Details)

v3.24.3
Significant Transactions - Summary of Asset Acquisition (Details) - RubrYc Therapeutics - USD ($)
Sep. 19, 2022
Aug. 23, 2021
Stock Purchase Agreement    
Business Acquisition [Line Items]    
Purchase price allocated   $ 7,500,000
Stock Purchase Agreement | Preferred Stock    
Business Acquisition [Line Items]    
Purchase price allocated   1,760,000
Stock Purchase Agreement | Intangible Assets    
Business Acquisition [Line Items]    
Purchase price allocated   4,300,000
Stock Purchase Agreement | Prepaid Expenses    
Business Acquisition [Line Items]    
Purchase price allocated   $ 1,440,000
Asset Purchase Agreement    
Business Acquisition [Line Items]    
Purchase price allocated $ 1,342,000  
Asset Purchase Agreement | Intangible Assets    
Business Acquisition [Line Items]    
Purchase price allocated 1,228,000  
Asset Purchase Agreement | Fixed Assets    
Business Acquisition [Line Items]    
Purchase price allocated $ 114,000